ANOTHER OF BIOHK2022'S TOPICS NOT TO MISS DEVELOPMENTS AGAINST CANCER
香港国际生物科技展另一个不能錯過的话题 抗癌发展
ESSENTIAL 必不可少 As one of the leading causes of death worldwide the field of Cancer research remains a top priority in the healthcare and biotech industry. In 2018, the estimated Cancer incidence and mortality burden worldwide was 18.8 million and in the next 20 years this number is predicted to increase by 60%. 作为全球主要死亡原因之一,癌症研究领域仍然是医疗保健和生物科技行业的重中之重。 2018年全世界癌症发病率和死亡率估计为1880万,预计在未来20年,这个数字将增加60%。
VALUABLE 高价值 At BIOHK2022 we are actively taking part in accelerating the developments against Cancer, exploring the ways to better predict the changes in Cancer worldwide, novel and effective techniques in screening and diagnostics, enhancing our understanding of Cancer to better target and develop new treatments against this disease. With the increasing use of technology across all industries we further explore the role of integrating technology in empowering our ability to conduct clinical assessments with AI and robotics, analyse new and existent data with big data analytics and enhancing our capabilities in screening and diagnostics. Do not miss out on a chance to listen to the world’s most renowned speakers in the Cancer field. This is the single best opportunity to reach the most influential members in this industry. 在香港国际生物科技展,我们积极参与加速癌症治疗的发展,探讨如何更好地预测全球癌症的变化,新颖有效的筛查和诊断技术,增进我们对癌症的了解,从而更好地针对和开发该疾病的新疗法 。随着各行各业对技术的日益应用,我们进一步探讨了集成技术在增强我们利用AI和机器人进行临床评估,利用大数据分析方法分析新数据和现有数据,以及在增强筛查和诊断能力方面的作用。 不要错过听取癌症领域全球最知名演讲者声音的机会。 这是接触该行业最有影响力的成员的唯一最佳机会。
CALLING ALL HONG KONG AND ASIA-BASED EARLY STAGE ONCOLOGY TECHNOLOGY COMPANIES!
WE STRONGLY ENCOURAGE YOU TO APPLY TO PARTICIPATE IN THE BRIDGING RESEARCH FROM ACADEMIA TO CANCER ENTREPRENEURSHIP (BRACE) AWARD VENTURE COMPETITION
A program of the Asian Fund for Cancer Research, a co-organizer of BIOHK2022, the BRACE Award Venture Competition offers financial and other support to oncology start-ups which most biopharmaceutical corporations and investors deem as at too early a stage, including those recently spun-out of Cancer research laboratories.
Participants will:
From among submitted applications, semi-finalists will be selected in October and the BRACE Award Venture Competition will be conducted virtually on Friday, 20 November. Two finalists will be decided upon that day, and, subject to due diligence, the winner will be announced at BIOHK2022 and receive HK$2,000,000 in AFCR investment! DEADLINE TO APPLY: MONDAY, 31 AUGUST 2020
SPEAKER ANNOUNCEMENT 演讲嘉宾公告
Dr Bruce E. Johnson
Chief Clinical Research Officer, Dana-Farber Cancer Institute
丹娜—法伯癌症研究所首席临床研究官 Dr Raju Kucherlapati
Professor, Harvard Medical School
哈佛医学院教授 Dr Alfred W.K. Yung
Professor, UT MD Anderson Cancer Center
德州大学安德森癌症中心教授 Dr Grace G.Y. Zhou
President, Shenzhen International Institute for Biomedical Research
深圳罗兹曼国际转化医学研究院院长
The above speakers will be joining us at BIOHK2022 discussing cancer related topics. Dr Raju Kucherlapati and Dr Alfred W.K. Yung were previously on the presentation evaluation panel for the 2019 BRACE Awards.
We are always open for new speakers! If there is someone you know who would make an excellent addition to our event, feel free to nominate them by letting us know.
以上演讲嘉宾将会在香港国际生物科技展上讨论与癌症相关的话题。 Raju Kucherlapati教授和Alfred W.K. Yung教授曾在2019年BRACE奖的评估小组中。
我们一直欢迎新的演讲嘉宾! 如果您身边认识一位出色的演讲嘉宾,请随时联络我们以作提名。
TOPICS 题目
CANCER CELL BIOLOGY & GENETICS
癌细胞生物学及遗传学
(Epigenetics, cancer stem cells, tumour biology, origins of cancer, oncogenes & proto oncogenes, tumour suppressor genes, aetiology, bioinformatics, pathology in cancer, cancer progression, genome studies)
(表观遗传学,癌症干细胞,肿瘤生物学,癌症起源,癌基因和原癌基因,肿瘤抑制基因,病因学,生物信息学,癌症病理学,癌症进展,基因组研究)
CANCER BIOMARKERS
癌症生物标志物
01
ITS USE IN DIAGNOSTICS, PREDICTION & PROGNOSIS / UTILISING CANCER BIOMARKERS: BENCH TO BEDSIDE
在诊断,预测和预后方面的用途 / 利用癌症生物标记物:从实验室到临床应用
02 MOST RECENT CANCER BIOMARKER DISCOVERIES AND VALIDATION TECHNIQUES
最近的癌症生物标志物发现和验证技术
03 NOVEL TECHNIQUES IN DISCOVERING BIOMARKERS
发现生物标记物的新技术
CANCER VACCINES
癌症疫苗
01
DEVELOPING AND PERSONALISING CANCER VACCINES
开发和个性化癌症疫苗
02 CANCER VACCINES: METHOD OF ACTION
癌症疫苗:作用机理
03 STRATEGIES IN DEVELOPING CANCER VACCINES
发展癌症疫苗的策略
04 FINDING SOLUTIONS IN ADDRESSING BARRIERS IN DEVELOPING CANCER VACCINES
不断发展的癌症疫苗中寻找障碍的解决方案
DIAGNOSTICS IN ONCOLOGY
肿瘤学诊断
01
ADVANCEMENTS IN DIGITAL HEALTH DEVICES
数位健康设备的进步
02 IMAGING AS A CRUCIAL TOOL IN DIAGNOSTICS
成像技术是诊断学的重要工具
03 AI IN CANCER DIAGNOSTICS
人工智能在癌症诊断中的应用
04 NOVEL APPROACHES IN EARLY DETECTION METHODS
早期检测方法中的新方法
05 REVEALING TUMOUR HETEROGENEITY THROUGH CANCER DIAGNOSTICS
通过癌症诊断揭示肿瘤异质性
06 DEVELOPING SCREENING TECHNIQUES: PRESENT ADVANCEMENTS
发展中的筛选技术:最新进展
07 DIAGNOSTICS AS A CRITICAL TOOL IN EVALUATING THE EXTENT OF THE SPREAD OF THE DISEASES
诊断作为评估疾病传播程度的关键工具
PREDICTION AND PREVENTION IN CANCER
癌症的预测和预防
01
PRACTICING AND PROMOTING PREVENTATIVE MEDICINE
开展和推广预防医学
02 ADVANCES IN EARLY DETECTION RESEARCH
早期检测研究的进展
03 RISK FACTORS PRESENT IN DAILY LIFE, THE NEED TO CHANGE LIFESTYLE CHOICES
日常生活中存在的风险因素,需要改变生活方式的选择
04 PUBLIC HEALTH REGIMES TO EDUCATE THE PUBLIC
透过公共卫生制度教育大众
05 VISUALISING CANCER AT AN EARLY STAGE
早期癌症的可视化
CANCER EPIDEMIOLOGY
癌症流行病学
01
EVALUATING THE MOST PREVALENT CANCERS IN HONG KONG AND THE GBA: WHY ARE THEY PREVALENT
评估香港和大湾区最流行的癌症:为何如此流行
Exclusive epidemiological analyses
独家流行病学分析
02 ANALYSING HOW THE PREVALENCE OF VARIOUS CANCERS ARE CHANGING WORLDWIDE AND PROGRESS IN THEIR RESEARCH
全球各种癌症的流行趋势如何变化及其研究进展
Investigating these changes and why these changes are occurring
调查这些变化以及发生变化的原因
03 RISK FACTORS IN OUR ENVIRONMENT (E.G. CARCINOGENS)
环境中的风险因素(例如致癌物)
04 GENE-ENVIRONMENT INTERACTIONS
基因与环境的相互作用
05 AETIOLOGY OF VARIOUS CANCERS
各种癌症的病因
06 EVOLUTIONARY PRESSURES DRIVING CANCER EMERGENCE
进化压力导致癌症的出现
MOST CURRENT DEVELOPMENTS IN CANCER THERAPY AND TREATMENTS
癌症治疗的新进展
01
REGULATING CANCER METABOLISM
调节癌症的新陈代谢
02 THERAPIES
治疗方式
Radiation therapy, immunotherapy, immuno-surveillance, immuno-editing, antibody and cytokine therapy, surgery, gene editing, chemotherapy
放射疗法,免疫疗法,免疫监测,免疫编辑,抗体和细胞因子疗法,手术,基因编辑,化疗
03 THE ROLE OF CHINESE MEDICINE IN CANCER TREATMENT
中医药在肿瘤治疗中的作用
04 STEM CELL TREATMENTS
干细胞治疗
05 HORMONAL TREATMENTS
激素治疗
06 DISCOVERING RELEVANT TARGETS IN CANCER TREATMENTS AND THERAPY
癌症治疗和治疗中相关靶点的发现
07 DRUG DEVELOPMENT IN CANCER (INDUSTRY 4.0 TECHNOLOGY IN DRUG DEVELOPMENT)
癌症药物开发(工业4.0药物开发技术)
08 REPURPOSING DRUGS
再利用藥物
09 EGFR- BASED TARGETED THERAPY
基于表皮細胞生長因子的靶向治疗
ADDRESSING MENTAL HEALTH IN CANCER
解决癌症中的心理健康問題
01
THE IMPORTANCE OF PSYCHOLOGICAL SUPPORT IN CANCER
心理辅导在對抗癌症中的重要性
GLOBAL PROGRESS AGAINST CANCER – CHALLENGES AND OPPORTUNITIES
全球抗癌进展 - 挑战及机遇
01
COLLABORATION EFFORTS BETWEEN RESEARCH AND TECHNOLOGICAL ADVANCES IN TREATING CANCER AND MINIMISING THE SIDE EFFECTS FROM BOTH CANCER AND TREATMENTS
研究和技术进步在治疗癌症以及最小化癌症和治疗的副作用之间的合作努力
e.g. Applications of 3-D Printing
例如 3-D打印的应用
...... AND MORE ...... 及更多
BIOHK2022 is the first international biotech convention to be held in Hong Kong and one of the first face-to-face meetings after COVID-19 for all to enjoy. BIOHK will present an exceptional international biotech kaleidoscope event to you. 香港国际生物科技展是首个在香港举行的国际生物科技展,也是2019新型冠状病毒病爆发之后第一批线下会议之一。 BIOHK将为您呈现一场国际生物科技万花筒盛会。
Copyright © 2022 Hong Kong Biotechnology Organisation. All rights reserved. Changed your mind? You can unsubscribe at any time.
版权所有 © 2022 香港生物科技协会 不再想要接收这些电子邮件? 按此退订
|